Helix Acquisition Corp. II (HLXB) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Helix Acquisition Corp. II reported revenue of $0. Net income was -$134.0M, or -$4.30 per diluted share. Operating activities generated -$113.9M of cash, leaving -$114.5M of free cash flow. At fiscal year end, Helix Acquisition Corp. II held $448.4M in total assets against $37.3M in total liabilities, including $373.7M of cash and equivalents.
Open the full interactive Helix Acquisition Corp. II financials → Quarterly statements, key ratios, valuation history and price charts.
Helix Acquisition Corp. II Key Stats
| Share Price | $2.95 |
|---|---|
| Market Cap | $236.2M |
| 52-Week Range | $2.95 – $13.73 |
| Shares Outstanding | 80.1 million (basic, 2026 Q2) |
Helix Acquisition Corp. II Income Statement
| FY 2024 | FY 2025 | |
|---|---|---|
| Revenue | $0 | $0 |
| Operating Income | -$584,389 | -$145.8M |
| Pre-Tax Income | $7.6M | -$134.0M |
| Income Tax | $0 | $0 |
| Net Income | $7.6M | -$134.0M |
| Diluted EPS | $0.36 | -$4.30 |
Helix Acquisition Corp. II Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$44.8M | -$89.7M | -$42.1M | -$56.5M |
| Diluted EPS | -$1.03 | -$2.88 | -$526.11 | -$0.71 |
Helix Acquisition Corp. II Balance Sheet
| FY 2024 | FY 2025 | |
|---|---|---|
| Cash & Equivalents | — | $373.7M |
| Current Assets | $1.9M | $432.4M |
| Total Assets | $194.4M | $448.4M |
| Current Liabilities | $187,515 | $35.0M |
| Total Liabilities | $5.7M | $37.3M |
| Shareholders' Equity | -$3.7M | $411.1M |
Helix Acquisition Corp. II Cash Flow Statement
| FY 2024 | FY 2025 | |
|---|---|---|
| Cash From Operations | -$763,820 | -$113.9M |
| Cash From Investing | -$184.0M | $73.3M |
| Cash From Financing | $186.5M | $383.4M |
| Free Cash Flow | — | -$114.5M |
Figures from Helix Acquisition Corp. II's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Helix Acquisition Corp. II financials page for every line item.
Helix Acquisition Corp. II Company Profile
| Ticker | HLXB |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | South San Francisco, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001869105 |
Frequently Asked Questions
What was Helix Acquisition Corp. II's revenue in fiscal 2025?
Helix Acquisition Corp. II (HLXB) reported revenue of $0 for fiscal 2025.
What was Helix Acquisition Corp. II's net income in fiscal 2025?
Helix Acquisition Corp. II reported net income of -$134.0M for fiscal 2025.
What was Helix Acquisition Corp. II's earnings per share (EPS) in fiscal 2025?
Helix Acquisition Corp. II's diluted EPS was -$4.30 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Helix Acquisition Corp. II generate in fiscal 2025?
Helix Acquisition Corp. II generated -$114.5M of free cash flow in fiscal 2025.
What was Helix Acquisition Corp. II's revenue last quarter?
In its most recent reported quarter (2026 Q2), Helix Acquisition Corp. II reported revenue of $0.
How many shares of Helix Acquisition Corp. II are outstanding?
Helix Acquisition Corp. II reported a weighted average of 80.1 million basic shares outstanding in 2026 Q2.
What is Helix Acquisition Corp. II's market cap?
Based on its latest closing price, Helix Acquisition Corp. II (HLXB) has a market capitalization of about $236.2M.
When does Helix Acquisition Corp. II's fiscal year end?
Helix Acquisition Corp. II's fiscal year end, as registered with the SEC, is December 31.
Where is Helix Acquisition Corp. II headquartered?
Helix Acquisition Corp. II lists its business address in South San Francisco, California in its SEC filings.